AIDS Research Alliance Gains Exclusive Rights To New Technology from Stanford ... ( License will...)

AIDS Research Alliance Gains Exclusive Rights To New Technology from Stanford University

Date:2/8/2010

License will accelerate the development of prostratin—the first in a new class of drugs for the treatment of HIV/AIDS.

(PRWEB) February 8, 2010 --AIDS Research Alliance announced today the signing of a new licensing agreement with Stanford University, transferring exclusive rights of a novel technology developed by Dr. Paul Wender and colleagues of Stanford to AIDS Research Alliance. This new technology (Science, Vol 320, p 649-652, 2 May 2008) will allow AIDS researchers to synthesize the natural compound, prostratin. Early tests conducted at the National Cancer Institute (NCI) and on-going pre-clinical studies conducted by AIDS Research Alliance indicate that prostratin targets latent HIV—the virus not killed by existing anti-HIV therapies. Previously, prostatin had to be collected from natural resources—an expensive and cumbersome process.

“Dr. Wender’s genius removes a major hurdle to the therapeutic development of this promising compound,” said Carolyn H. Carlburg, President & CEO of AIDS Research Alliance. The ability to produce prostratin synthetically will significantly reduce future costs, making prostratin a more viable drug candidate, Carlburg said.

“When used in combination with existing antiretroviral drugs, prostratin may one day help treating physicians eradicate all virus from the body—a feat not yet possible using existing therapies,” stated Dr. Stephen J. Brown, Medical Director at AIDS Research Alliance.

Dr Brown explains: “Current therapies suppress the virus, but they do not completely eradicate virus from
'/>"/>

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. Marijuana ineffective as an Alzheimers treatment: UBC-Vancouver Coastal Health research
2. Nuvo Research announces early redemption of 5% convertible debentures
3. Researcher to track spread of disease, malware and power outages
4. UCSF Researchers Identify Regulator of Human Sperm Cells
5. Octapharma Accepting Applications for Research Grants Through March 31
6. Valentine Tailgate Party for the Girls with Festive Ideas from Beauty Research
7. New Research Shows Genes of Pregnant Women and Their Fetuses Can Increase the Risk of Preterm Labor
8. Developing a cyberinfrastructure for comparative effectiveness in cancer research
9. Women should be allowed to eat, drink during labor: Queens University researcher
10. Parkinsons disease research uncovers social barrier
11. Fear of Frailty: Research Shows Lack of Activity Threatens Seniors' Independence

Post Your Comments:

Related Image:

AIDS Research Alliance Gains Exclusive Rights To New Technology from Stanford University

(Date:5/23/2013)... Aortic arch pulse wave velocity, a measure of ... of the vessels that supply blood to the brain, ... issue the journal Radiology . , "Pulse ... about vessel compliance that may help determine a patient,s ... S. King, M.D., assistant professor of radiology at UT ...

(Date:5/23/2013)... (PRWEB) May 23, 2013 Hormones drive many ... muscle tone, fat build-up, sleep quality, sex drive, how productive ... are getting older are driven by declining hormone levels as ... dehydroepiandrosterone, is the most abundant foundation or base from which ... body gradually increase until about age 25, when we are ...

(Date:5/23/2013)... OH (PRWEB) May 23, 2013 Aero ... has been selected by NewWave Biosciences to be the ... and health care professionals. , Brad Cole, CEO ... number of reasons including their central location, e-commerce experience ... care professionals) and overall end-to-end solution that will expand ...

(Date:5/23/2013)... 23, 2013 Looking for tips on how ... sensitive issue of caring for your aging parent? ... (NAPGCM) released the results of a survey of 335 ... , Here are the top 5 tips identified ... percentage of survey respondents selecting each option): , 1. Give each ...

(Date:5/23/2013)... with high-risk neuroblastoma a common tumor that forms in ... cancer drugs. A study published by Cell Press in ... reveals a new genomic approach to screen for ... cells to differentiate, or convert from immature cells to ... researchers identified a compound that causes neuroblastoma cells to ...

Breaking Medicine News(10 mins):Health News:MRI-based measurement helps predict vascular disease in the brain 2 Health News:Health2Go Announces Research That DHEA Helps Depression 2 Health News:Health2Go Announces Research That DHEA Helps Depression 3 Health News:Health2Go Announces Research That DHEA Helps Depression 4 Health News:NewWave Biosciences Chooses Aero Fulfillment for e-Commerce Distribution of New Product to Reduce Inflammation 2 Health News:New Survey of Aging Experts Gives Top 5 Tips for Avoiding Family Feud when Caring for Aging Parents 2 Health News:New screening approach uncovers potential alternative drug therapies for neuroblastoma 2

[0] MRI-based measurement helps predict vascular disease in the brain [0] Health2Go Announces Research That DHEA Helps Depression [0] NewWave Biosciences Chooses Aero Fulfillment for e-Commerce Distribution of New Product to Reduce Inflammation [0] New Survey of Aging Experts Gives Top 5 Tips for Avoiding Family Feud when Caring for Aging Parents [0] New screening approach uncovers potential alternative drug therapies for neuroblastoma

... diets also associated with higher income levels, study finds ... higher levels of education and income tend to eat ... are less energy-dense (lower calorie/higher nutrient content), a U.S. ... lower rates of obesity, type 2 diabetes, cardiovascular disease ...

... Tech Rapid Alert System Enables Hospitals to Rapidly Notify Staff, Community ... ... Clark, New Jersey, May 1, 2009 -- Mobile Health Tech, the ... 2.0 of its Hospital Rapid Notification Alert System™. This new release ...

... Female Health Company (NYSE Amex: FHC ) today ... discuss its operating results for the second quarter and first ... Friday, May 8, 2009. The Company expects to report ... earlier the same day. Shareholders and other interested parties may ...

... IL Ankle sprains are a common injury after a fall, ... of those who suffer an ankle sprain will experience chronic ankle ... , A review article published in the May 2009 issue of ... (JAAOS) explains that tendon injuries to the ankle can be ...

... delicious and active Mediterranean lifestyle are curePALM BAY, Fla., ... more likely we are to maintain a healthy diet ... diet than that eaten in the Mediterranean?In his new ... ( published by iUniverse ), Ray Adamcik ...

... Over Prior YearNEW YORK, May 1 HMS (Nasdaq: ... March 31, 2009. For the first quarter of 2009, revenue increased ... period a year ago. Net income for the quarter was $5.7 ... of $3.2 million or $0.12 per fully diluted share for the ...

More Educated Choose Healthier Foods, But Pay More Hospital Rapid Alert System Supports Swine Flu Pandemic Communications The Female Health Company Schedules Second Quarter Conference Call for May 8, 2009 Chronic ankle pain may be more than just a sprain 'The Globe's Best Diet: The Metabolic Syndrome Cure'HMS Holdings Corp. Announces First Quarter 2009 Financial Results

(Date:5/23/2013)... 2013 Inhibikase Therapeutics, Inc., an emerging leader ... will present new results on its antiviral program ... by the PML Consortium (composed of Pfizer, Bristol-Meyers ... is the causative agent of Progressive Multifocal Leukoencephalopathy ... an extended release formulation, can clear JC polyomavirus ...

(Date:5/23/2013)... -- Echo Pharma Acquisition Limited ("Royalty Pharma") announced today that ... from 90 percent to 50 percent of Maximum Elan ... the terms of the Revised Offer Document issued today, ... the terms of the Increased Offer, Royalty Pharma is ... for $12.50 per share in cash. The Increased Offer ...

(Date:5/23/2013)... BOTHELL, Wash. , May 23, 2013 ... and marketer of proprietary clinical grade hypothermic storage ... and tissues, and contract aseptic media manufacturer , ... Stem Cells & Regenerative Medicine Congress 2013 this ... (Logo: http://photos.prnewswire.com/prnh/20090814/BIOLIFELOGO ) Dr. Aby J. ...

[0] Inhibikase Therapeutics to present at Industry Conference on Drug-Induced Progressive Multifocal Leukoencephalopathy (PML)[0] Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share [0] BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress

... CENTER VALLEY, Pa., Dec. 7, 2011 /PRNewswire-iReach/ ... leader in designing and delivering innovative solutions in ... announces the release of Acecide ® -C, a ... exclusively for use in the Olympus Endoscope Reprocessor, ...

... Dec. 7, 2011 Data from the MarginProbe pivotal ... San Antonio Breast Cancer Symposium. The results were ... Surgery, NYU Langone Medical Center, New York University, ... randomized study, adjunctive use of MarginProbe significantly improved ...

Cached Medicine Technology:Olympus Introduces New Peracetic Acid Solution for Rapid High-Level Disinfection 2 Olympus Introduces New Peracetic Acid Solution for Rapid High-Level Disinfection 3 MarginProbe® Pivotal Study Presented at San Antonio Breast Cancer Symposium 2

Olympus Introduces New Peracetic Acid Solution for Rapid High-Level Disinfection MarginProbe® Pivotal Study Presented at San Antonio Breast Cancer Symposium

100% Silicone Foley Catheter Kits 2-Way...

ULTRAMER Foley Catheter...

Foley Catheters (Latex) 2-Way...

Silicone Elastomer-Coated Latex Foley Catheters 3-Way...

Medicine Products:

DOVER 100% Silicone Foley Catheter Kits 2-Way DOVER ULTRAMER Foley Catheter ULTRAMER Foley Catheters (Latex) 2-Way DOVER Silicone Elastomer-Coated Latex Foley Catheters 3-Way